665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101 - Aix-Marseille Université Access content directly
Journal Articles Annals of Oncology Year : 2021

665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101

M-O. Grimm
  • Function : Author
M. Oya
  • Function : Author
T.K. Choueiri
  • Function : Author
M. Schmidinger
  • Function : Author
D.I. Quinn
  • Function : Author
Gwenaelle Gravis Mescam
Institut Paoli-Calmettes
Centre de Recherche en Cancérologie de Marseille
CV
E. Verzoni
  • Function : Author
A.J.M. van den Eertwegh
  • Function : Author
A. Di Pietro
  • Function : Author
M. Mariani
  • Function : Author
J. Wang
  • Function : Author
D. Thomaidou
  • Function : Author
L. Albiges
  • Function : Author

Domains

Cancer Immunotherapy

Jacques A NUNES  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03623392

Submitted on : Tuesday, March 29, 2022-4:45:08 PM

Last modification on : Friday, March 24, 2023-2:53:26 PM

Consult the full text

Dates and versions

hal-03623392 , version 1 (29-03-2022)

Identifiers

Cite

M-O. Grimm, M. Oya, T.K. Choueiri, M. Schmidinger, D.I. Quinn, et al.. 665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101. Annals of Oncology, 2021, 32, pp.S690-S691. ⟨10.1016/j.annonc.2021.08.061⟩. ⟨hal-03623392⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM
5 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More